Ipsos Health - Our approach

Our research approach is developed from an integrated framework of thinking, which focuses on the interaction of the multiple customer groups pharmaceutical companies have to focus on. We utilise a framework of thinking rather than limiting ourselves to an off-the-shelf product. We use modular approaches, rather than branded solutions to a business issue, as we believe that every product and every therapy area has its unique challenges that cannot be force-fit into a single-solution approach.

We believe in

• A framework of thinking for key business issues, which enables both global consistency and at the same time local tailoring to individual market conditions
• Providing respondents with realistic prescribing scenarios to react to, rather than relying on claimed behaviour
• Assessing issues from multiple view points, for instance, establishing the emotional, behavioural and environmental factors impacting behaviour, in addition to the rational
• Using non-verbal data capture, such as ethnography and patient illustrations to enrich and deepen quantitative data

Across markets, we have in-house, healthcare specialised moderators for qualitative research who understand how to conduct deep analysis in a single market and how to scale this across numerous markets

We have pharmaceutical experts in over 30 countries -including emerging markets, yet we are organised globally as one Ipsos Health research team. We share best practice and market knowledge through our monthly Network of Innovation and Excellence (NEXI) meetings and we are linked together through our global knowledge centre.